Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 994 entries
View as:

Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

Phase: N/A Priority: Normal
NCT ID: NCT03904069 Org: User:
Start: 03/13/23 End: 08/07/30 Due: 08/07/31

Open-label Safety and Pharmacokinetic Study of DUEXIS® (Ibuprofen and Famotidine) Tablets in Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01563185 Org: User:
Start: 04/30/12 End: 03/31/15 Due: 03/31/16

A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00306189 Org: User:
Start: 01/31/06 End: 11/30/07 Due: 11/30/08

Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)

Phase: N/A Priority: Normal
NCT ID: NCT04506086 Org: User:
Start: 08/26/21 End: 09/16/24 Due: 09/16/25

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05767047 Org: User:
Start: 03/23/23 End: 03/17/36 Due: 03/17/37

A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04129164 Org: User:
Start: 12/09/19 End: 03/10/23 Due: 03/10/24

Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00116701 Org: User:
Start: 05/31/05 End: - Due: -

Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone

Phase: N/A Priority: Normal
NCT ID: NCT04586660 Org: User:
Start: 08/17/23 End: 03/07/28 Due: 03/07/29

Evaluating the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI)in Subjects With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00111423 Org: User:
Start: 08/31/02 End: - Due: -

AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to Splenectomy

Phase: N/A Priority: Normal
NCT ID: NCT00102323 Org: User:
Start: 03/29/05 End: 03/01/07 Due: 03/01/08

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01949545 Org: User:
Start: 10/31/13 End: 09/30/15 Due: 09/30/16

A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00883181 Org: User:
Start: 11/30/06 End: 09/30/14 Due: 09/30/15

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00111761 Org: User:
Start: 07/31/02 End: 10/31/08 Due: 10/31/09

A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06088199 Org: User:
Start: 10/24/23 End: 07/06/26 Due: 07/06/27

A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)

Phase: N/A Priority: Normal
NCT ID: NCT05398445 Org: User:
Start: 05/31/22 End: 01/13/25 Due: 01/13/26

The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam

Phase: N/A Priority: Normal
NCT ID: NCT01221727 Org: User:
Start: 11/30/10 End: 07/31/11 Due: 07/31/12

Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01901146 Org: User:
Start: 04/29/13 End: 01/27/17 Due: 01/27/18

Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03934684 Org: User:
Start: 09/16/19 End: 06/24/25 Due: 06/24/26

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Phase: N/A Priority: Normal
NCT ID: NCT01077154 Org: User:
Start: 06/02/10 End: 03/26/18 Due: 03/26/19

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Phase: N/A Priority: Normal
NCT ID: NCT00597909 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

Nplate® Pregnancy Exposure Registry

Phase: N/A Priority: Normal
NCT ID: NCT02090088 Org: User:
Start: 05/31/09 End: 01/31/14 Due: 01/31/15

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04583735 Org: User:
Start: 09/02/21 End: 10/12/23 Due: 10/12/24

A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Phase: N/A Priority: Normal
NCT ID: NCT05317078 Org: User:
Start: 02/28/23 End: 04/01/24 Due: 04/01/25

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT03451422 Org: User:
Start: 04/10/18 End: 10/12/21 Due: 10/12/22

A Study to Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06411860 Org: User:
Start: 10/10/24 End: 12/11/24 Due: 12/11/25